Advertisement Phase Forward's CFO to retire - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Phase Forward’s CFO to retire

Phase Forward, a provider of data management solutions for clinical trials and drug safety, has announced that Rodger Weismann will retire as CFO of the company, effective June 1, 2009.

Christopher Menard, currently Phase Forward’s vice president of finance, will succeed Weismann as CFO at that time. After June 1, 2009 Weismann will serve in a part-time capacity as advisor to the CEO in a variety of areas, including strategic planning and corporate development.

Mr Menard joined Phase Forward in 2001, and in his current role as vice president of finance, he manages worldwide finance and accounting groups that have responsibility for accounting, financial reporting, budgeting, treasury and compliance, external audits and Securities and Exchange Commission reporting.

Mr Menard has received a bachelor of science degree in business administration from Babson College and an MBA from Boston College.

Rodger Weismann, CFO of Phase Forward, said: “As I look to transition the CFO role, the company is fortunate to have a highly qualified candidate ready to take over. For some time, Chris Menard has had responsibility for managing most of Phase Forward’s financial departments on a worldwide basis.”